Lee K W, Park J W, Joh J W, Kim S J, Choi S H, Heo J S, Lee H H, Lee D S, Park J H, Yoo B C, Paik S W, Koh K C, Lee J H, Choi M S, Lee S K
Department of Surgery, Division of Gastroenterology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Transplant Proc. 2004 Oct;36(8):2289-90. doi: 10.1016/j.transproceed.2004.08.144.
The Milan criteria, namely, tumors 5 cm or less in diameter in patients with single hepatocellular carcinoma (HCC), no more than 3 tumor nodules, and each 3 cm or less in diameter in patients with multiple tumors, are accepted for cadaveric liver allocation. However, in living donor liver transplantation (LDLT), graft donation may only depend on the donor's intention. The aim of this study was to elucidate the feasibility of Milan criteria in LDLT.
From January 2001 to December 2002, 46 cases of liver transplantation (LT) for HCC included 5 hospital mortalities and 3 cadaveric transplantations, all of which were excluded. We classified the patients into Group I cases that met the Milan criteria and Group II cases that did not meet the Milan criteria. The analyses examined tumor-related risk factors affecting recurrence and survival, such as tumor size, number of tumor nodules, and presence of microvascular and macrovascular invasion.
Twenty-one cases belonged to Group I and 17 to Group II. There was no significant difference in the recurrence or survival rates between Groups I and II. The risk factors affecting recurrence were macrovascular invasion and tumor size (5 cm). The number of tumor nodules and microvascular invasion did not appear to affect recurrence. The risk factor affecting survival was macrovascular invasion.
We suggest that in selected cases the Milan criteria could be extended to increase the number of tumor nodules as long as the HCC were small and did not macrovascular invasion.
米兰标准,即单发性肝细胞癌(HCC)患者肿瘤直径5厘米或更小,多发性肿瘤患者肿瘤结节不超过3个且每个直径3厘米或更小,已被用于尸体肝脏分配。然而,在活体肝移植(LDLT)中,移植物捐献可能仅取决于供体的意愿。本研究的目的是阐明米兰标准在LDLT中的可行性。
2001年1月至2002年12月,46例因HCC进行肝移植(LT)的患者中有5例医院死亡病例和3例尸体肝移植病例,均被排除。我们将患者分为符合米兰标准的I组病例和不符合米兰标准的II组病例。分析研究了影响复发和生存的肿瘤相关危险因素,如肿瘤大小、肿瘤结节数量以及微血管和大血管侵犯情况。
I组有21例,II组有17例。I组和II组在复发率或生存率方面无显著差异。影响复发的危险因素是大血管侵犯和肿瘤大小(5厘米)。肿瘤结节数量和微血管侵犯似乎不影响复发。影响生存的危险因素是大血管侵犯。
我们建议,在某些特定病例中,只要HCC体积小且无大血管侵犯,米兰标准可扩展以增加肿瘤结节数量。